Chiffres calculés à partir des déclarations réglementaires officielles — .
Détentioninitiés 0% · institutions 0% · vente à découvert 0.0% du flottant
En USD · au Oct 26, 2026
Interroger la machine
Recherchez et comparez les opérations d’initiés, les sociétés et leurs statistiques en langage courant. Votre question devient une requête sur les données disponibles, pas une conversation ni un conseil en investissement.
Données de AOXING PHARMACEUTICAL COMPANY, INC. uniquement. Pas de recherche web. Les statistiques globales d’un initié sont exclues.
Une recherche exécutée consomme un crédit, même sans résultat. Les erreurs et les questions non prises en charge ne consomment rien.
Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain. Its products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. was incorporated in 1996 and is based in Foster City, California.
Source des informations de marché · Oct 26, 2026
Périodes présentes dans les registres consultés. Elles ne certifient pas les dates juridiques de changement de nom.
Identité selon la SEC · Oct 26, 2026
Chronologie sur le marché · historique complet
9 achats— cours de clôturebarre = volume usd, échelle √cliquez sur une période pour filtrer le tableau
| Initié | Type | Valeur · USD | Signaux | Détail | |
|---|---|---|---|---|---|
| Zhang Guoan | Attribution | $27.2K | SEC | ||
| Chow Wilfred | Attribution | $136K | SEC | ||
| Chow Wilfred | Attribution | $260K | SEC | ||
| Yue Zhenjiang | Attribution | $2.8M | SEC | ||
| Zhang Guoan | Attribution | $92.7K | SEC | ||
| Zhang Guoan | Attribution | $324.1K | SEC | ||
| OSHEA JOHN Phistorique | Attribution | $7.3K | SEC | ||
| OSHEA JOHN Phistorique | Attribution | $7.3K | SEC | ||
| OSHEA JOHN Phistorique | Attribution | $7.3K | SEC | ||
| Ai Bob Yunjun | Attribution | $4.6K | SEC | ||
| OSHEA JOHN Phistorique | Attribution | $5.2K | SEC | ||
| Xu Guozhu | Attribution | $5.2K | SEC | ||
| Ai Bob Yunjun | AttributionD (dérivé) | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC | ||
| OSHEA JOHN Phistorique | Attribution | $7.3K | SEC | ||
| OSHEA JOHN Phistorique | Attribution | $7.3K | SEC | ||
| OSHEA JOHN Phistorique | Attribution | $7.3K | SEC | ||
| OSHEA JOHN Phistorique | Attribution | $7.7K | SEC | ||
| OSHEA JOHN Phistorique | Attribution | $7.3K | SEC | ||
| OSHEA JOHN Phistorique | Attribution | $35.3K | SEC | ||
| Xu Guozhu | Attribution | $8K | SEC | ||
| OSHEA JOHN Phistorique | Attribution | $8K | SEC | ||
| Sterling Howard David | Attribution | $8K | SEC | ||
| Yue Zhenjiang | Autre | $2.2M | SEC | ||
| OSHEA JOHN Phistorique | Attribution | $7.3K | SEC | ||
| Zhang Guoan | Achat | $4.6K | conv 41 | SEC |